The compliance score as a regressor in randomized trials

By Joffe M.M.   Have T.R.T.   Brensinger C.  

Biostatistics, Vol. 4, Iss. 3, 2003-07 ,pp. : 327-340

Oxford University Press

Access to resources Recommend Favorite

A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments

By Fischer Krista   Goetghebeur Els   Vrijens Bernard   White Ian R.  

Biostatistics, Vol. 12, Iss. 2, 2011-04 ,pp. : 247-257

Oxford University Press

Access to resources Recommend Favorite

Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials

By Naci H.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 4, 2013-04 ,pp. : 299-306

Oxford University Press

Access to resources Recommend Favorite

Randomized Controlled Trials in Pouchitis

By  

Reviews on Recent Clinical Trials, Vol. 7, Iss. 4, 2012-11 ,pp. : 303-306

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials*

By Vakily Majid   Zhang Weijiang   Wu Jingtao   Atkinson Stuart N.   Mulford Darcy  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 627-638

Informa Healthcare

Access to resources Recommend Favorite